The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

20 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.EBI
School of Life Science Nanjing University
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.EBI
Nanjing University
QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III.EBI
Shri G.S. Institute of Technology and Science
Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors.EBI
Portland State University
Synthesis and biological evaluation of a C5-biphenyl thiolactomycin library.EBI
University of Birmingham
Structure-activity relationships at the 5-position of thiolactomycin: an intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coli.EBI
National Institute of Allergy and Infectious Diseases
Discovery of vinylogous carbamates as a novel class ofß-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.EBI
Soochow University
Synthesis, molecular modeling and biological evaluation ofß-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents.EBI
Nanjing University
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.EBI
Nanjing University
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.EBI
Nanjing University
Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics.EBI
Konkuk University
Synthesis and biological evaluation of thiazolidine-2-one 1,1-dioxide as inhibitors of Escherichia coli beta-ketoacyl-ACP-synthase III (FabH).EBI
Portland State University
Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.EBI
The University of Birmingham
Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase.EBI
Nanjing University
Discovery of novel bacterial FabH inhibitors (Pyrazol-Benzimidazole amide derivatives): Design, synthesis, bioassay, molecular docking and crystal structure determination.EBI
Fudan University
Synthesis, molecular modeling and biological evaluation of PSB as targeted antibiotics.EBI
Nanjing University
Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics.EBI
Nanjing University
Indazoles and use thereofBDB
Purdue Pharma
Biological and structural evaluation of 10R- and 10S-methylthio-DDACTHF reveals a new role for sulfur in inhibition of glycinamide ribonucleotide transformylase.BDB
The Scripps Research Institute
Hydroxyethylene isosteres of selective neuronal nitric oxide synthase inhibitors.BDB
Northwestern University